Iran’s Hypertension and Diabetes Mellitus Surveillance System and Its Implementation Challenges: A Case Study of Tehran Uni- versity of Medical Sciences
Abstract
Introduction: Surveillance systems play a vital role in managing non-communicable diseases (NCDs). This study explores the challenges encountered in the implementation of Iran's hypertension (HTN) and diabetes surveillance system, using Tehran University of Medical Sciences (TUMS) as a case study.
Methods: This study employed a two-part approach, consisting of a literature review and an expert panel discussion. In the first part, a literature review was conducted using PubMed and Google Scholar, encompassing studies published between 2000 and 2023 in both Persian and English. The objectives of this review were to: 1) investigate the history of diabetes and HTN surveillance system and 2) identify implementation challenges of the surveillance system for these conditions. The sources included national guidelines, health surveys, published reports, and academic papers. In the second part, five expert panel discussions (formal focus groups) were conducted semi-structured with seven TUMS specialists. These sessions aimed to pinpoint the challenges
in implementing diabetes and HTN surveillance in Iran. Finally, data from both parts were analyzed using conventional content analysis with an inductive approach and were categorized and coded using MAXQDA software to extract the key challenges in implementing the surveillance system.
Results: The National HTN Prevention and Control Program was initiated in 1992 and later expanded its focus to include individuals (both males and females) aged 30 and older in rural areas. In 2004, it merged with the National diabetes Prevention and Control Program, which was established in 1991. This program primarily targeted high-risk individuals aged 15 to 39, as well as those over 40 in selected pilot rural areas. Together, these programs now address both HTN and diabetes prevention through the IraPEN program, launched in 2014. The analysis identified three main categories and eleven subcategories, resulting in a total of 78 codes. The issues have been categorized into three areas: healthcare recipients (lack of public awareness and social issues), healthcare system employees (staffing issues and inadequate training), and upper levels of the healthcare system (ineffective policies, poor evaluation and monitoring, outdated facilities, weak management, insufficient data, and financial constraints).
Conclusion: The study identifies challenges within Iran's healthcare system that impede surveillance programs. To improve outcomes, we should prioritize public education, provide better support for healthcare workers, and implement stronger management practices. By adopting these changes, we can enhance the surveillance systems for HTN and diabetes.
2. Pati MK, Swaroop N, Kar A, Aggarwal P, Jayanna K, Van Damme W. A narrative review of gaps in the provision of integrated care for noncommunicable diseases in India. Public health reviews. 2020;41:8.
3. Yildiz M, Esenboğa K, Oktay AA. Hypertension and diabetes mellitus: highlights of a complex relationship. Current opinion in cardiology. 2020;35(4):397-404.
4. Hinneh T, Akyirem S, Bossman IF, Lambongang V, Ofori-Aning P, Ogungbe O, et al. Regional prevalence of hypertension among people diagnosed with diabetes in Africa, a systematic review and meta-analysis. PLOS global public health. 2023;3(12):e0001931.
5. Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL, Sacre JW, Karuranga S, et al. IDF diabetes
Atlas: Global estimates of undiagnosed diabetes in adults for 2021. Diabetes research and clinical
practice. 2022;183:109118.
6. Gulec S. Early diagnosis saves lives: focus on patients with hypertension. Kidney international supplements. 2013;3(4):332-4.
7. World Health Organization (WHO). Global Report on Hypertension: The Race Against a Silent Killer. September 19, 2023. https://iris.who.int/bitstream/handle/10665/372896/9789240081062-eng.pdf?sequence=1.
8. Kengne AP, Ramachandran A. Feasibility of prevention of type 2 diabetes in low-and middleincome countries. Diabetologia. 2024;67(5):763-72.
9. Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T. Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis. BMJ open. 2022;12(4):e056627.
10. Butt MD, Ong SC, Rafiq A, Kalam MN, Sajjad A, Abdullah M, et al. A systematic review of the economic burden of diabetes mellitus: contrasting perspectives from high and low middleincome countries. Journal of pharmaceutical policy and practice. 2024;17(1):2322107.
11. Schutte AE, Srinivasapura Venkateshmurthy N, Mohan S, Prabhakaran D. Hypertension in Low- and Middle-Income Countries. Circulation research. 2021;128(7):808-26.
12. Gordis, L. (2014). Epidemiology. United States: Elsevier/Saunders. https://books.google.com/books?id=oS_0mgEACAAJ
13. Ahmadi S, Sajjadi H, Nosrati Nejad F, Ahmadi N, Karimi SE, Yoosefi M, et al. Lifestyle modification strategies for controlling hypertension: How are these strategies recommended by physicians in Iran? Medical journal of the Islamic Republic of Iran. 2019;33:43.
14. ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al. Prevention or delay of diabetes and associated comorbidities: Standards of care in diabetes—2023. Diabetes Care 2023;46(Supplement_1):S41-8.
15. Sadrizadeh B. Health situation and trend in the Islamic Republic of Iran. Iranian Journal of Public Health. 2001;30(1-2):1-8.
16. Farzadfar F, Murray CJ, Gakidou E, Bossert T, Namdaritabar H, Alikhani S, et al. Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study. The Lancet. 2012;379(9810):47-54.
17. Principles, criteria and standards of the healthcare network (Health Development Document).2021. https://www.skums.ac.ir/DorsaPax/userfiles/Sub19/estan.pdf.
18. Samavat T, Hodjatzadeh A. Programs for the prevention and control of cardiovascular diseases. Center for Non-Communicable Disease Control, Office of Cardiovascular, Ministry of Health and Medical Education. 2011.
19. IraPEN: tailoring the WHO PEN for NCD prevention and control to the national context. https://x.gd/VZ9hT
20. Kosha A, Najmi M, Mahdavi Hazaveh A, Moghisi A, Ghanbari Motlagh A, Yarahmadi S, et al. Package of Essential NonCommunicable (PEN) Disease Interventions for Primary Health Care in Iran (IraPEN). Center for Non-Communicable Disease Control, Ministry of Health and Medical Education. 2017.
21. Ministry of Health and Medical Education. National Blood Pressure Control Program. ,Center for Non-Communicable Disease Control, Ministry of Health and Medical Education,Tehran,Iran (2019).
22. Shams M, Pariani A, Raeisi A, Maleki M, Shariatinia S, Jamalizadeh A, et al. The Iranian National Blood Pressure Measurement Campaign: What Do the Process and Output Evaluation say? Archives of Iranian medicine. 2022;25(11):718-24.
23. Delavari A, Mahdavi Hazaveh A, Nprouzinezhad A, Yarahmadi S. National Diabetes Prevention and control program. Department of Endocrinology and Metabolic, Center for Disease Control, Ministry of Health and Medical Education. Tehran,Iran: Seda Publishing Center; 2004.
24. Alavi Nia M, Ghotbi M, Kermanchi J, Mahdavi Hazaveh A, Nasli Esfahani A, Yarahmadi S. National Program for Prevention and Control of Diabetes Type II in Urban Areas. Department of Endocrinology and Metabolic Center for Non-Communicable Disease Control Office of Hospital Administration and Clinical Service Excellence Treatment Deputy Ministry of Health and Medical Education, editor Tehran, Iran. 2012.
25. Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. EMHJ-Eastern Mediterranean Health Journal. 2003;9 (5-6):1114-21.
26. Ghotbi M, Rafati M, Ahmadinia H. Noncommunicable Diseases Surveillance system - National guidelines Surveillance system for noncommunicable diseases. Tehran, Iran: Sepidbarg; 2008. Principles of Disease Prevention and Care.
27. Samavat T, Hodjatzadeh A, Naderiasiabar Z. National high blood pressure prevention and control program. Center for Non-Communicable Disease Control, Ministry of Health and Medical Education. 2002.
28. Ahmadi S, Rafiey H, Sajjadi H, Nosrati Nejad F, Ahmadi N, Yoosefi M, et al. Trend and pattern of using herbal medicines among people who are aware of their diabetes mellitus: results from National STEPs Surveys in 2005 to 2011 in Iran. Journal of diabetes and metabolic disorders. 2021;20(2):1319-25.
29. Djalalinia S, Azadnajafabad S, Ghasemi E, Yoosefi M, Rezaei N, Farzi Y, et al. Protocol Design for Surveillance of Risk Factors of Non-communicable Diseases During the COVID-19 Pandemic: An Experience from Iran STEPS Survey 2021. Archives of Iranian medicine. 2022;25(9):634-46.
30. Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol Design for Large-Scale Cross-Sectional Studies of Surveillance of Risk Factors of Non-Communicable Diseases in Iran: STEPs 2016. Archives of Iranian medicine. 2017;20(9):608-16.
31. Azizi F, Zadeh-Vakili A, Takyar M. Review of Rationale, Design, and Initial Findings: Tehran Lipid and Glucose Study. International journal of endocrinology and metabolism. 2018;16(4 Suppl):e84777.
32. Poustchi H, Eghtesad S, Kamangar F, Etemadi A, Keshtkar AA, Hekmatdoost A, et al. Prospective Epidemiological Research Studies in Iran (the PERSIAN Cohort Study): Rationale, Objectives, and Design. American journal of epidemiology. 2018;187(4):647-55.
33. Shirjang A, Mahfouzpour S, Masoudiasl I, Doshmangir L. Challenges of primary healthcare in Iran towards achieving universal health coverage: A qualitative study. Journal of Urmia Nursing and Midwifery Faculty. 2020;18(2) (Serial No. 127):166-179. https://sid.ir/paper/407932/fa.
34. Kabir MJ, Rafiei N, Heidari A, Alidoost S, Saraili Z, Foroughi Z, et al. Challenges of Payment System to Primary Health Care Providers in Iranian Comprehensive Health Centers. Journal of azandaran University of Medical Sciences. 2023;32(216):151-73.
35. Etemad K, Heidari A, Panahi M, Lotfi M, Fallah F, Sadeghi S. A challenges in implementing package of essential noncommunicable diseases interventions in Iran’s healthcare system. Journal of health esearch in community. 2016;2(3):32-43.
36. Damari B, Heidari A. Implementation model of integrated management for prevention and control of non-communicable diseases in Iran. Payesh. 2019;19(1):7-17. Available from: https://sid.ir/paper/23904/fa.
37. Ghorbanzadeh S, Khodayari-Zarnag R, Babaie J. A qualitative study of barriers, facilitators, and challenges of providing high-quality hypertension care in health centers in Iran: perspectives of healthcare care workers, patients, and health center managers. Journal of Qualitative Research in Health Sciences. 2023;12(4):220-6.
38. Zanganeh Baygi M, Peyvand M. Blood Pressure National Campaign in Iran: Experiences of Service Recipients-A Qualitative Study. Journal of Health Sciences & Surveillance System. 2021;9(4):243-52.
39. Sadeghi S, Mahani F, Amiri P, Alamdari S, Khalili D, Saadat N, et al. Barriers toward the national program for prevention and control of diabetes in Iran: a qualitative exploration. International Journal of Health Policy and Management. 2022;12:6908.
40. Valizadeh R, Vali L, Bahaadinbeigy K, Amiresmaili M. The challenges of Iran's type 2 diabetes prevention and control program. International journal of preventive medicine. 2019;10(1):175.
41. Khatib R, Schwalm J-D, Yusuf S, Haynes RB, McKee M, Khan M, et al. Patient and healthcare provider barriers to hypertension awareness, treatment and follow up: a systematic review and metaanalysis of qualitative and quantitative studies. PloS one. 2014;9(1):e84238.
42. Khezri R, Ravanipour M, Motamed N, Vahedparast H. Effect of Self-Management Empowering Model on the Quality of Life in the Elderly Patients With Hypertension. Salmand: Iranian Journal of Ageing. 016;10(4):68-79.
43. Khan HT, Addo KM, Findlay H. Public health challenges and responses to the growing ageing populations. Public Health Challenges. 2024;3(3):e213.
44. Coombs NC, Campbell DG, Caringi J. A qualitative study of rural healthcare providers' views of social, cultural, and programmatic barriers to healthcare access. BMC Health Serv Res. 2022;22(1):438.
45. Partovi Y, Farahbakhsh M, Tabrizi JS, Gholipour K, Koosha A, Sharbafi J, et al. The challenges facing programs for the prevention and control of non-communicable diseases in Iran: a qualitative study of senior managers' viewpoints. BMC Health Services Research. 2022;22(1):1354
| Files | ||
| Issue | Vol 11 No 2 (2025) | |
| Section | Articles | |
| DOI | https://doi.org/10.18502/jbe.v11i2.20553 | |
| Keywords | ||
| Hypertension Diabetes Surveillance System Challenges Iran | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
